IDEX BIOMETRICS ASA
Reference is made to the private placement of about 83.2 million shares in IDEX Biometrics ASA on 15 February 2021. The capital increase has been registered. The company’s share capital is now NOK 137,304,213.30 divided into 915,361,422 shares, each with a par value of NOK 0.15.
A listing prospectus will be prepared and published as soon as practical. About 29.4 million of the new shares have been issued to a separate, temporary ISIN and that will be restricted from trading on Oslo Børs until after publication of the prospectus.
For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 9180 0186
Derek D’Antilio, Chief Financial Officer
E-mail: derek.dantilio@idexbiometrics.com
Tel: +1 978 273 1344
About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading provider of fingerprint identification technologies offering simple, secure and personal touch-free authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices or gain admittance to buildings. We invent, engineer, and commercialize these secure and safe yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.
For more information, visit www.idexbiometrics.com and follow @IDEXBiometrics.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Bitget Limited22.11.2025 07:00:00 CET | Press release
Bitget Supports Earthquake Relief Efforts in Northern Cebu Through Community-Led Donation Drive
Strategic Partners A/S22.11.2025 01:51:44 CET | Pressemeddelelse
PERIODEMEDDELELSE 3. KVARTAL 2025:
Teva Pharmaceutical Industries Ltd21.11.2025 22:30:00 CET | Press release
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December
INVENTIVA21.11.2025 22:00:00 CET | Press release
Inventiva reports 2025 Third Quarter Financial Information¹
Solvay S.A.21.11.2025 17:45:00 CET | Press release
Participation notifications by Morgan Stanley
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
